Valeo Financial Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1722641
CARMEL, IN
Position in REGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$803,743
-$197,598 QoQ
Shares Held
1,289
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#690
of 1,319 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $6,495,341 across 14 Biotechnology names. REGN ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,787 | $1,881,116 | |
| 2 | ARGX |
Argenx SE
|
1,077 | $999,208 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,289 | $803,743 | |
| 4 | RLAY |
Relay Therapeutics, Inc.
|
35,687 | $667,703 | |
| 5 | MRNA |
Moderna, Inc.
|
7,412 | $519,062 | |
| 6 | VCEL |
Vericel Corp
|
9,289 | $413,267 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
6,033 | $331,453 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,838 | $241,563 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $803,743 | 1,289 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,001,341 | 1,296 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,245,026 | 1,613 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,049,195 | 1,866 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $943,425 | 1,797 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $753,465 | 1,188 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $891,124 | 1,251 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,626,268 | 1,547 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,161,388 | 1,105 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $861,428 | 895 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $562,105 | 640 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $509,412 | 619 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $370,766 | 516 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $504,505 | 614 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $328,999 | 456 | Shares | Sole | 2023-02-09 | |
| 2021-12-31 | $245,661 | 389 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $231,783 | 383 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $203,308 | 364 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $170,330 | 360 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $251,217 | 520 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $290,525 | 519 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $278,771 | 447 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $207,523 | 425 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||